Abbott develops and delivers health care technologies and products. The company focuses on various sectors of health care, including diagnostics and nutrition. Self-described as a provider of life-changing solutions.

Abbott

NAVICA

my a:care

myMerlinPulse™

MyFreeStyle Foodie x Diabetes

myMerlinPulse™ - EUC

Abbott Nutritional App

ALP Loyalty Program

Amplatzer™ Portfolio

VertiGo Exercise (AR)

myMerlinPulse™ - SEA

Executive Vice President Finance, Chief Financial Officer

Bob Funck

DVP & Associate General Counsel, Corporate Legal

Craig Bryson

Divisional Vice President and Associate General Counsel

David Mendelson

Divisional Vice President and Associate General Counsel; Nutrition, Est. Pharma, and Diagnostics

David Walters

Divisional VP and Associate General Counsel

Erica Battaglia

Divisional Vice President & Associate General Counsel, Structural Heart & Vascular

Jason Bedell

Jessica Paik

President

Katherine Horn

Divisional Vice President & Associate General Counsel, Core Diagnostics

Katie Jernigan

President, Abbott Molecular

Keith Cienkus

Samuel Scott

Phebe Novakovic

Roxanne Austin

Michelle Kumbier

Erin Delacroix

Sally Blount

Nancy McKinstry

Robert Alpern

Kathleen Thrush

Section Manager, Clinical Operations

Todd Johnson

Vice President

Miles White

Chief Executive Officer

Julie Tyler

Senior Vice President, Vascular

Jennifer Ranaldi

Structural Heart, Mitraclip

Sabina Ewing

Chief Information Officer

Shamini Nair

Global Marketing Director

Richard Woolhouse

Regional Head Business Economics and Strategy Europe

Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes.

Respicardia develops implantable therapies to improve respiratory and cardiovascular health.

Evalve engages in the design, development, manufacture, and marketing of devices that enable the repair of cardiac valves.

Alere provides diagnostics and health management solutions for infectious, heart and cancer-related diseases and drug addicts.

Midwestern US Public Companies With More Than 1000 Employees

Medical Public Companies With More Than $50M in Revenue

Pharmaceutical Public Companies With More Than 50 Employees

Biotechnology Companies that Exited

Abbott is engaged in pharmaceuticals and manufacturing healthcare products. It developed the first HIV blood-screening test. Its product portfolio includes Norvir, a treatment for HIV, Synthroid, a synthetic thyroid hormone, Depakote, an anticonvulsant drug, and Humira, a drug for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and more.

Post-IPO Debt - Abbott

Illinois City

Illinois

United States

North America

Seamless Data: Tidepool and Abbott’s New Cloud-to-Cloud Integration Partnership

Abbott advancing PFA studies, launches cardiac mapping tool

Abbott Laboratories Analyst Is Bullish About MedTech, Non-MedTech Growth

Abbott started at outperform by Oppenheimer, diversified portfolio cited (NYSE:ABT)

Abbott pricing in higher NEC liability than expected, says Jefferies

**Abbott Launches Comprehensive Cardiovascular Health Website**

Abbott Declares 403rd Consecutive Quarterly Dividend

Abbott's Lingo glucose monitoring system available in the U.S.

Abbott, Baxter and Medtronic among firms hit with recalls

Abbott expands pump partnerships, launches Lingo CGM

India

Asia

Costa Rica

Singapore

Germany

Europe

HTML5

Google Analytics

Office 365

Google Tag Manager

Symantec Email Security.Cloud

Google Drive

Facebook

Amazon EC2

Fonts.com

Cloudflare CDN

Abbott owns STARLIMS

Abbott owns MedNova

Abbott owns Integrated Vascular Systems

Abbott owns Experimental and Applied Sciences

Abbott owns CFR Pharmaceuticals

Abbott owns Artären AB

Abbott owns Abott Diagnostics

Abbott owns Abbott Ventures

Abbott owns Abbott Vascular

Abbott owns Abbott Nutrition Manufacturing

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 26, 2024 1:58 PM	6b03c59e
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Sep 26, 2024 1:58 PM	9108115f
crunchbase trigger	general	Oct 28, 2024 1:51 PM	67a1aa7d
crunchbase profile	general	Oct 28, 2024 1:58 PM	2e4894e9
li profile	general
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	0549998e
peers	general	Sep 26, 2024 1:58 PM	b7554734
news basic	general	Sep 26, 2024 1:58 PM	1b65bfce
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:ABBOTT

Abbott